Identification of a novel nurr1-interacting protein.
Luo Y, Xing F, Guiliano R, Federoff HJ
Researchers identify a new protein, NuIP, that binds to Nurr1 and enhances its ability to activate genes critical for dopamine neuron function. Suppressing NuIP in cell models reduces cell division and lowers the expression of the dopamine transporter.
- NuIP specifically interacts with the ligand-binding domain of Nurr1.
- NuIP potentiates Nurr1-driven transcription from dopamine-related promoters.
- NuIP and Nurr1 colocalize in adult midbrain dopaminergic neurons.
- Silencing NuIP decreases cell division and dopamine transporter expression.
FGF-8 stimulates the expression of NR4A orphan nuclear receptors in osteoblasts.
Lammi J, Aarnisalo P
This study shows that FGF-8 stimulates NR4A receptor expression in bone-forming cells, a process unrelated to the neurological symptoms of NR4A2 syndrome. The findings focus on osteoblast proliferation and differentiation pathways rather than dopaminergic neuron function or brain development.
- FGF-8 induces NR4A receptors in osteoblasts via MAPK and PI-3K pathways.
- NR4A receptors mediate the growth-promoting effects of FGF-8 in bone cells.
- The study uses mouse cell lines, not human patients or neural tissue.
- No connection to NR4A2-related neurodevelopmental disorders or Parkinsonism is established.
Effect of the co-administration of vitamin C and vitamin E on tyrosine hydroxylase and Nurr1 expression in the prenatal rat ventral mesencephalon.
Lee HY, Naha N, Ullah N, Jin GZ, Kong IK, Koh PO, Seong HH, Kim MO
This study shows that vitamins C and E increase the expression of Nurr1 and tyrosine hydroxylase in developing rat brain cells. The combination of these vitamins produces a stronger effect than either vitamin alone.
- Vitamins C and E boost Nurr1 protein levels in prenatal rat brain tissue.
- Vitamin C specifically increases tyrosine hydroxylase expression.
- Combining vitamins C and E creates a synergistic increase in both proteins.
- The study uses cultured rat cells, not human subjects or clinical trials.
Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra.
Han BS, Iacovitti L, Katano T, Hattori N, Seol W, Kim KS
This study maps where the LRRK2 gene is active in the brain, finding it present in both dopamine-producing neurons and surrounding non-dopamine cells. It confirms that LRRK2 is highly expressed in the specific A9 dopamine neurons of the substantia nigra that are affected in Parkinson's disease.
- LRRK2 exists in both dopamine neurons and nearby non-dopamine cells in the midbrain.
- The gene shows strong expression specifically in A9 dopamine neurons of the substantia nigra.
- Results suggest mutant LRRK2 may directly cause the selective death of these specific neurons.
Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines.
Doi Y, Oki S, Ozawa T, Hohjoh H, Miyake S, Yamamura T
This study identifies NR4A2 as a driver of inflammation in T cells within the context of multiple sclerosis, an autoimmune condition distinct from NR4A2-related syndromes. The research demonstrates that reducing NR4A2 levels lowers inflammatory cytokines and reduces disease severity in mouse models.
- NR4A2 drives inflammatory cytokine production in T cells during multiple sclerosis.
- Reducing NR4A2 via siRNA lowers IL-17 and IFN-gamma levels in mice.
- Lower NR4A2 reduces the ability of T cells to transfer disease in animal models.
- Findings focus on autoimmune mechanisms, not dopaminergic neuron development or function.
Expression of functional dopaminergic phenotype in purified cultured Müller cells from vertebrate retina.
Kubrusly RC, Panizzutti R, Gardino PF, Stutz B, Reis RA, Ventura AL, de Mello MC, de Mello FG
Retinal glial cells (Müller cells) can produce and release dopamine when cultured, a process driven by the Nurr1 transcription factor. This finding demonstrates that non-neuronal glial cells possess intrinsic dopaminergic machinery independent of neuronal influence.
- Purified Müller cells synthesize dopamine from L-DOPA in culture.
- These cells express key enzymes and transporters for dopamine processing.
- Nurr1 is present in these glial cells, supporting their dopaminergic role.
- Dopamine release occurs via transporter-mediated mechanisms.
- This biology is specific to retinal glia, not central nervous system neurons.
Nurr1 transcriptionally regulates the expression of alpha-synuclein.
Yang YX, Latchman DS
Reduced levels of the Nurr1 protein cause an increase in alpha-synuclein expression, a mechanism linked to Parkinson's disease. This finding establishes a direct molecular link between NR4A2 function and alpha-synuclein regulation.
- Decreased Nurr1 transcriptionally increases alpha-synuclein expression.
- This mechanism is observed in Parkinson's disease contexts.
- The study uses cell-based models to demonstrate this regulation.
Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro.
Choudhary S, Huang H, Raisz L, Pilbeam C
This study shows that blocking a specific enzyme (COX-2) allows parathyroid hormone to stimulate bone growth in mouse cells, revealing a mechanism where natural prostaglandins normally inhibit this process. The research identifies NR4A2 as one of the genes activated by this pathway, but it does not test treatments for NR4A2-related syndromes or address neurological symptoms.
- PTH stimulates bone growth in mouse cells only when COX-2 is blocked.
- NR4A2 gene expression increases significantly under these specific experimental conditions.
- The study uses mouse cell cultures, not human patients or clinical data.
- Findings relate to bone biology, not the neurological aspects of NR4A2 syndrome.
Comparative analysis of transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel immune response players in T-cell activation.
Wang M, Windgassen D, Papoutsakis ET
This study maps gene activity in T-cells during immune activation and identifies NR4A2 as one of several genes involved in communication between different T-cell subsets. It provides no information on NR4A2's role in the brain, neurodevelopment, or potential treatments for NR4A2-related syndromes.
- NR4A2 appears only as an incidental marker in this immunology study.
- The research focuses on T-cell activation, not neurological function.
- No clinical data, patient phenotypes, or treatment insights are provided.
- Findings do not translate to understanding NR4A2-related neurodevelopmental disorders.
Extracellular signal-regulated kinases (ERK) and protein kinase C (PKC) activities are involved in the modulation of Nur77 and Nor-1 expression by dopaminergic drugs.
Bourhis E, Maheux J, Rouillard C, Lévesque D
Dopamine-acting drugs change Nur77 and Nor-1 gene activity through specific cellular signaling pathways involving MEK and PKC enzymes. These findings map the molecular mechanisms by which dopamine drugs influence these receptors, but they do not provide direct evidence for treating NR4A2-related syndromes in humans.
- Dopamine drugs modulate Nur77 and Nor-1 via MEK and PKC signaling pathways.
- Nur77 and Nor-1 respond differently to dopamine agonists versus antagonists.
- This is preclinical research using animal models, not human clinical data.
- The study focuses on basic molecular biology rather than therapeutic outcomes.
Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy.
Meyer U, Engler A, Weber L, Schedlowski M, Feldon J
Maternal immune activation in pregnant mice increases the number of dopamine-producing neurons in the fetal brain and alters key developmental genes. This suggests that prenatal infection can directly modify early brain development pathways relevant to neurotransmitter systems.
- Mouse study shows maternal immune challenge boosts fetal dopamine neuron counts.
- Prenatal inflammation changes expression of Nurr1, Pitx3, Shh, and Fgf8 genes.
- Findings link maternal infection to altered dopaminergic system development in fetuses.
Alpha-chemokines regulate proliferation, neurogenesis, and dopaminergic differentiation of ventral midbrain precursors and neurospheres.
Edman LC, Mira H, Erices A, Malmersjö S, Andersson E, Uhlén P, Arenas E
Alpha-chemokines increase the number of functional dopamine-producing neurons in rat brain cell cultures. These findings suggest potential applications for developing cell therapies for Parkinson's disease.
- CXCL6 promotes differentiation of Nurr1+ precursors into dopamine neurons in vitro.
- CXCL8 enhances progenitor division and increases dopamine neuron numbers in rodent cells.
- Treated neurons are functional, showing calcium fluxes in response to stimulation.
- Study uses rat ventral midbrain cultures, not human patients or NR4A2 variants.
CREB has a context-dependent role in activity-regulated transcription and maintains neuronal cholesterol homeostasis.
Lemberger T, Parkitna JR, Chai M, Schütz G, Engblom D
This study uses mouse models to show that CREB and CREM proteins regulate the Nr4a2 gene in specific brain regions depending on the stimulus, such as seizures or drug exposure. It also finds that losing these proteins disrupts cholesterol metabolism in the brain.
- CREB and CREM selectively control Nr4a2 expression in mouse hippocampus and striatum.
- CREM can compensate for missing CREB in regulating activity-induced gene transcription.
- Loss of CREB/CREM disrupts cholesterol synthesis and accumulation in mouse brains.
Sall3 is required for the terminal maturation of olfactory glomerular interneurons.
Harrison SJ, Parrish M, Monaghan AP
Sall3 is essential for the final development of specific neurons in the olfactory bulb's glomerular layer, which are critical for processing smell. Without Sall3, these neurons fail to mature properly, leading to reduced numbers and loss of key neurotransmitters, though early neuron formation appears normal.
- Sall3 is needed for final maturation of olfactory glomerular neurons
- Loss of Sall3 reduces interneuron numbers in the olfactory bulb
- Neurotransmitters like dopamine and GABA are disrupted
- Early neuron development and migration remain intact
- Sall3 deficiency causes loss of tyrosine hydroxylase in olfactory bulb
Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease.
Hedlund E, Pruszak J, Lardaro T, Ludwig W, Viñuela A, Kim KS, Isacson O
Researchers successfully purified midbrain dopamine neurons from mouse embryonic stem cells and transplanted them into rats with Parkinson's disease, where the grafts survived and restored motor function. This study demonstrates that enriched dopaminergic neuron populations can effectively integrate and function in an animal model of neurodegeneration. The work provides proof-of-concept for cell purification strategies but does not involve human patients or NR4A2-specific genetics.
- Purified mouse stem-cell-derived dopamine neurons survived transplantation in Parkinson's rats.
- Enriched grafts restored motor function and innervated the host striatum.
- Study uses animal models, not human clinical data or NR4A2 variants.
- Demonstrates feasibility of cell sorting for potential future cell therapies.
Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopaminergic phenotype.
Greschat S, Schira J, Küry P, Rosenbaum C, de Souza Silva MA, Kögler G, Wernet P, Müller HW
Human stem cells from umbilical cord blood differentiate into dopamine-producing neurons when treated with specific growth factors. These cells express key dopaminergic markers, release dopamine, and show electrical activity characteristic of mature neurons.
- Umbilical cord blood stem cells become functional dopamine-producing neurons in lab dishes.
- Specific growth factors trigger the expression of Nurr1 and tyrosine hydroxylase.
- The derived cells synthesize and release dopamine neurotransmitter.
- Cells exhibit electrical properties typical of mature neurons.
Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells.
Sharma R, Ottenhof T, Rzeczkowska PA, Niles LP
Melatonin promotes neuronal differentiation and increases histone H3 acetylation in neural stem cells. The treatment upregulates Nurr1 expression alongside other neuronal markers via the MT(1) receptor.
- Melatonin induces neurite-like extensions in C17.2 neural stem cells.
- Treatment increases mRNA expression of the neuronal marker beta-III-tubulin.
- Melatonin significantly upregulates Nurr1 gene expression in these cells.
- Histone H3 acetylation increases, suggesting epigenetic modulation of transcription.
- Effects appear mediated by the MT(1) melatonin receptor.
Melanocortin-1 receptor signaling markedly induces the expression of the NR4A nuclear receptor subgroup in melanocytic cells.
Smith AG, Luk N, Newton RA, Roberts DW, Sturm RA, Muscat GE
This study shows that skin cell signaling pathways activate NR4A genes to help repair DNA damage from UV light. It does not provide information about the neurological symptoms or treatment of NR4A2-related syndrome in children.
- MC1R signaling triggers NR4A gene expression in melanocytes.
- NR4A activation helps repair UV-induced DNA damage in skin cells.
- Specific MC1R variants impair this protective DNA repair mechanism.
- The research focuses on pigmentation and cancer risk, not neurology.
Transcriptional regulation of mesencephalic dopaminergic neurons: the full circle of life and death.
Alavian KN, Scholz C, Simon HH
This review explains how Nurr1 and other transcription factors guide the development, maintenance, and survival of dopamine-producing neurons in the brain. It highlights that these genes are critical for both forming these neurons during embryonic stages and keeping them healthy throughout life.
- Nurr1 helps establish dopamine neuron location and identity in the midbrain.
- These transcription factors ensure long-term survival of existing dopamine neurons.
- The paper reviews mechanisms relevant to Parkinson's disease pathology.
- It does not present new clinical data or treatment trials for NR4A2.
Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
Lammi J, Perlmann T, Aarnisalo P
This study explains the molecular mechanism by which Nurr1 activates gene transcription when paired with RXR, focusing on how ligand binding releases corepressor proteins. It identifies specific regions in the Nurr1 protein responsible for this interaction but does not test any treatments or analyze human patients.
- Nurr1 forms heterodimers with RXR to regulate gene transcription as a monomer or partner.
- RXR ligand binding releases corepressors SMRT and NcoR from RXR-Nurr1 complexes.
- The amino-terminal part of Nurr1's ligand binding domain drives this permissive interaction.
- RXR-RAR heterodimers remain bound to corepressors until RAR ligands bind.
- This is basic molecular biology with no direct clinical application or human data.
Gene Ontology-driven transcriptional analysis of CD34+ cell-initiated megakaryocytic cultures identifies new transcriptional regulators of megakaryopoiesis.
Fuhrken PG, Chen C, Apostolidis PA, Wang M, Miller WM, Papoutsakis ET
This study identifies NR4A2 as a transcription factor expressed in human megakaryocytes, expanding the known network of genes regulating blood cell development. It provides no information on neurological function, disease mechanisms, or potential treatments for NR4A2-related syndromes.
- NR4A2 is confirmed to be present in human megakaryocyte cells.
- The research focuses solely on blood cell differentiation pathways.
- No findings relate to the brain, dopamine, or neurodevelopment.
- The paper does not discuss clinical phenotypes or patient outcomes.
- Results are limited to molecular biology of hematopoietic stem cells.
Orphan nuclear receptor NOR-1 enhances 3',5'-cyclic adenosine 5'-monophosphate-dependent uncoupling protein-1 gene transcription.
Kumar N, Liu D, Wang H, Robidoux J, Collins S
This study identifies a mechanism by which the NR4A2 family of proteins helps regulate brown fat metabolism in response to cold and stress signals. The findings describe how these receptors bind to DNA to increase the production of UCP1, a protein involved in heat generation. This work focuses on metabolic tissue regulation rather than neurological development or disease treatment.
- NR4A2 family proteins bind directly to the Ucp1 gene promoter to stimulate its transcription.
- Cold exposure and beta-agonists rapidly induce NR4A receptor expression in mouse and human adipocytes.
- Blocking NR4A activity prevents the stimulation of Ucp1 gene transcription by beta-adrenergic signals.
- The study defines a specific DNA sequence motif required for this metabolic regulation.
Proneural bHLH neurogenin 2 differentially regulates Nurr1-induced dopamine neuron differentiation in rat and mouse neural precursor cells in vitro.
Park CH, Kang JS, Yoon EH, Shim JW, Suh-Kim H, Lee SH
This study shows that the interaction between Nurr1 and neurogenin 2 differs significantly between rat and mouse cells, complicating the translation of these findings to humans. The results highlight species-specific variations in dopamine neuron development that limit the direct applicability of this animal model data.
- Nurr1 efficiently generates dopamine neurons in rat neural precursor cells.
- Nurr1 produces low and variable dopamine neuron yields in mouse cells.
- Neurogenin 2 suppresses Nurr1-induced dopamine neuron generation in rats.
- Neurogenin 2 enhances Nurr1-induced dopamine neuron generation in mice.
- Findings suggest species-dependent differences in midbrain dopamine neuron development.
Differential expression and dynamic changes of murine NEDD9 in progenitor cells of diverse tissues.
Aquino JB, Marmigère F, Lallemend F, Lundgren TK, Villar MJ, Wegner M, Ernfors P
This study maps where the protein NEDD9 appears in developing mouse tissues, finding it overlaps with NR4A2 (Nurr1) in early neural progenitor cells before disappearing as those cells mature. The research provides no information on human health, treatment options, or the specific effects of NR4A2 mutations.
- The study uses mouse embryos, not human patients or clinical data.
- It focuses on NEDD9, a scaffolding protein, rather than NR4A2 function.
- NEDD9 overlaps with Nurr1 in early neural progenitors but drops off upon maturation.
- No therapeutic insights or genotype-phenotype correlations for NR4A2 syndromes are presented.
Genotype patterns that contribute to increased risk for or protection from developing heroin addiction.
Nielsen DA, Ji F, Yuferov V, Ho A, Chen A, Levran O, Ott J, Kreek MJ
This study identifies NR4A2 as one of five genes potentially associated with heroin addiction risk in a specific human cohort. It does not provide information on the neurodevelopmental, motor, or language phenotypes relevant to children with NR4A2 syndrome.
- NR4A2 appears in a list of genes linked to heroin addiction vulnerability.
- The study uses a small cohort of Caucasian adults with severe addiction history.
- No data on developmental outcomes, epilepsy, or motor symptoms is presented.
- Findings relate to substance use disorder, not the child's syndrome.
Gene expression profile of neuronal progenitor cells derived from hESCs: activation of chromosome 11p15.5 and comparison to human dopaminergic neurons.
Freed WJ, Chen J, Bäckman CM, Schwartz CM, Vazin T, Cai J, Spivak CE, Lupica CR, Rao MS, Zeng X
This study maps gene activity in human stem cells as they develop into dopamine neurons, identifying a specific chromosome region that activates during this process. It confirms that genes involved in dopamine neuron development are expressed in these lab-grown cells and in mature human brain tissue.
- Researchers tracked gene expression in human stem cells differentiating into dopamine neurons.
- A chromosome region on 11p15.5 activates during the formation of neuronal precursors.
- Key dopamine-related genes like TH, IGF2, and CDKN1C show high activity.
- Findings in lab-grown cells match gene patterns in mature human brain samples.
A novel adipokine CTRP1 stimulates aldosterone production.
Jeon JH, Kim KY, Kim JH, Baek A, Cho H, Lee YH, Kim JW, Kim D, Han SH, Lim JS, Kim KI, Yoon DY, Kim SH, Oh GT, Kim E, Yang Y
CTRP1, a fat-derived protein, increases aldosterone production in human adrenal cells by boosting the activity of genes and proteins involved in hormone synthesis, including NURR1, and may link obesity and high blood pressure in humans.
- CTRP1 boosts aldosterone production in human adrenal cells
- CTRP1 increases NURR1 and aldosterone-making genes
- CTRP1 levels are high in obese and hypertensive people
- CTRP1 may connect obesity to high blood pressure
- CTRP1 is released in response to angiotensin II
Social isolation rearing-induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice.
Ibi D, Takuma K, Koike H, Mizoguchi H, Tsuritani K, Kuwahara Y, Kamei H, Nagai T, Yoneda Y, Nabeshima T, Yamada K
Social isolation in juvenile mice reduces hippocampal neurogenesis and impairs memory and behavior, an effect linked to decreased expression of the gene Nurr1 (NR4A2). Fluoxetine treatment prevents these cellular deficits and improves behavioral outcomes in this model. This study suggests that environmental factors during development may influence NR4A2-related pathways.
- Social isolation reduces new neuron survival and differentiation in juvenile mouse hippocampus.
- Isolated mice show impaired spatial memory and increased aggression.
- Fluoxetine prevents neurogenesis deficits and ameliorates behavioral impairments.
- Social isolation lowers expression of Nurr1 (NR4A2) and Npas4 genes.
- Findings link environmental stress to NR4A2-mediated developmental changes.
The NR4A family of orphan nuclear receptors are not required for adipogenesis.
Au WS, Payne VA, O'Rahilly S, Rochford JJ
NR4A2-related syndrome is not linked to fat cell development, as the NR4A family of genes—including NR4A2—plays no essential role in forming fat cells, according to studies in mouse cells.
- NR4A genes are not needed for fat cell formation
- Blocking NR4A activity does not stop fat cell development
- NR4A2 function in fat cells is likely minimal
- These genes are more important in liver and muscle metabolism
Expression and function of nr4a2, lmx1b, and pitx3 in zebrafish dopaminergic and noradrenergic neuronal development.
Filippi A, Dürr K, Ryu S, Willaredt M, Holzschuh J, Driever W
This study uses zebrafish to show that the NR4A2 protein is required for developing neurons to produce dopamine, confirming its role in neurotransmitter specification. It also identifies a related gene, Lmx1b, as important for generating precursor cells that eventually become dopaminergic neurons.
- NR4A2 activity is necessary for zebrafish neurons to express dopamine-related proteins.
- The study confirms NR4A2 helps specify the neurotransmitter phenotype in developing brains.
- Lmx1b genes support the creation of precursor cells for ascending dopaminergic systems.
- Pitx3 knockdown did not specifically affect diencephalic dopamine clusters in this model.
Angiotensin-II acute regulation of rapid response genes in human, bovine, and rat adrenocortical cells.
Nogueira EF, Vargas CA, Otis M, Gallo-Payet N, Bollag WB, Rainey WE
This study identifies NR4A2 as a gene rapidly activated by Angiotensin-II in adrenal cells across human, bovine, and rat models. The findings confirm that NR4A2 is a direct target of this signaling pathway in the adrenal cortex.
- NR4A2 activates quickly in response to Angiotensin-II stimulation.
- This regulation occurs directly without requiring new protein synthesis.
- The effect is consistent across human, bovine, and rat adrenal cells.
- NR4A2 joins other immediate-early genes in regulating aldosterone production.
Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease.
Bousquet M, Saint-Pierre M, Julien C, Salem N, Cicchetti F, Calon F
A high omega-3 diet protects dopaminergic neurons and preserves dopamine levels in mice exposed to a Parkinson's-inducing toxin. This neuroprotection occurs at the cellular level but does not prevent damage to nerve terminals in the striatum.
- High omega-3 intake prevents loss of nigral neurons in toxin-exposed mice.
- The diet preserves Nurr1 mRNA and dopamine transporter levels in the substantia nigra.
- Striatal dopamine and metabolite levels remain higher in omega-3 treated mice.
- Nerve terminals in the striatum show no protection from the diet.
mRNA expression of activity-regulated cytoskeleton-associated protein (arc) in the amygdala-kindled rats.
Akiyama K, Ishikawa M, Saito A
This study measures brain gene activity in rats with seizures and finds no direct evidence regarding NR4A2-related syndromes or human treatments. The research focuses on general seizure mechanisms rather than the specific genetic condition affecting your child.
- The study uses rat models of amygdala-kindling to observe brain changes during seizures.
- It tracks mRNA levels of arc, NGFI-B, and Nurr1 in specific brain regions after stimulation.
- Nurr1 expression increases temporarily in the piriform cortex and amygdaloid nucleus after seizures.
- The findings describe synaptic reorganization markers but do not address NR4A2 haploinsufficiency.
- No human data, clinical outcomes, or therapeutic implications for NR4A2 disorders are presented.